Redeye

21.5K posts

Redeye banner
Redeye

Redeye

@Redeye_

A members network for financial professionals and private investors. We keep our eyes focused on Nordic Tech and Life Science based companies with global reach.

Stockholm, Sweden Katılım Haziran 2010
253 Takip Edilen14.5K Takipçiler
Redeye
Redeye@Redeye_·
Our recent Theme Event Artificial Intelligence moved beyond the "shiny objects" to map out the full AI ecosystem. To capture a piece of a $1.3 Trillion market, you have to look at every layer. Check out the highlights below to see how representatives from Saab, Univrses and Warp News view the expanding AI landscape. Watch the full recording from the event and all the presentations here: redeye.se/events/1139435…
English
0
0
0
474
Redeye
Redeye@Redeye_·
Redeye Theme: Commercialization in Life Science is progressing! 10.55 iZafe – Marius Sandberg, CFO 11.15 Genovis – Fredrik Olsson, CEO 11.35 Alvotech – Patrik Ling, VP IR Tune in: redeye.se/events/1139438…
Redeye tweet media
English
0
0
0
485
Redeye
Redeye@Redeye_·
Redeye Theme: Commercialization in Life Science is LIVE! 09.30 Intro by Redeye 09.35 Moberg Pharma – Anna Ljung, CEO 09.55 Oncopeptides – Sofia Heigis, CEO 10.15 Hansa Biopharma – Maria Törnsén, President U.S. & COO Tune in: redeye.se/events/1139438…
Redeye tweet media
Română
0
0
0
526
Redeye
Redeye@Redeye_·
Redeye comments on Waystream receiving its first-ever order from Telia Sweden (SEK3m), marking an important milestone following the 2022 framework agreement and validating its position in its largest potential market. $WAYS redeye.se/research/11578…
Redeye tweet media
English
0
0
0
524
Redeye
Redeye@Redeye_·
Redeye comments on Insplorion communicating a higher bid for its core business from Consilium, totaling approximately SEK10m. $INSP redeye.se/research/11577…
Redeye tweet media
English
0
0
0
537
Redeye
Redeye@Redeye_·
Redeye provides an update on Biovica following the Q3 2025/2026 report, which overall came in slightly better than expected. $BIOVIC redeye.se/research/11576…
Redeye tweet media
English
0
0
0
447
Redeye
Redeye@Redeye_·
Redeye comments on the recent share price development in Sivers, following elevated trading activity and growing investor interest, while also discussing recent partnership developments in optical infrastructure. $SIVE redeye.se/research/11577…
Redeye tweet media
English
0
0
1
1.2K
Redeye
Redeye@Redeye_·
Redeye comments on Better Collective’s announcement of expansion into prediction markets with the launch of dedicated content and products for the segment, which we believe provides further support to a return to organic growth in 2026E. $BETCO redeye.se/research/11577…
Redeye tweet media
English
0
0
0
604
Redeye
Redeye@Redeye_·
Redeye comments on Genovis announcing a strategic partnership with Dutch CRO Single Cell Discoveries. $GENO redeye.se/research/11574…
Redeye tweet media
English
0
0
0
587
Redeye
Redeye@Redeye_·
Binero Group is trading below Redeye’s Bear Case. We spoke with our analyst about the company's growth prospects, what the current valuation is, and other key topics. This is a premium article, included in our paid plans from SEK 99/month. $BINERO redeye.se/research/11574…
Redeye tweet media
English
0
0
0
579
Redeye
Redeye@Redeye_·
Redeye comments on Xplora completing a NOK150m private placement at NOK52 per share — a reasonable 6.5% discount to the prior close — three days after announcing the Emporia Mobile acquisition. $XPLRA redeye.se/research/11574…
Redeye tweet media
English
0
0
0
535
Redeye
Redeye@Redeye_·
Redeye comments on AlzeCure Pharma presenting new preclinical data for NeuroRestore ACD856 at the AD/PD Conference in Copenhagen (17–21 March 2026). $ALZCUR redeye.se/research/11574…
Redeye tweet media
English
0
0
0
477
Redeye
Redeye@Redeye_·
Redeye comments on Enviro signing a non-binding LOI regarding licensing of its pyrolysis technology in North America, indicating continued interest from industrial counterparties. $SES redeye.se/research/11574…
Redeye tweet media
English
0
0
0
603
Redeye
Redeye@Redeye_·
Redeye is encouraged by FluoGuide receiving FDA Fast Track Designation for FG001 in High-Grade Glioma. $FLUO redeye.se/research/11574…
Redeye tweet media
English
0
0
1
450
Redeye
Redeye@Redeye_·
Redeye comments on Isofol’s expansion of its arfolitixorin license to include autism spectrum disorders, specifically targeting cerebral folate deficiency. $ISOFOL redeye.se/research/11573…
Redeye tweet media
English
0
0
0
609
Redeye
Redeye@Redeye_·
Redeye is positive to AAC’s press release today, which states an expected order value of more than EUR70m for the 20 microwave radiometers in the EPS-Sterna project. $AAC redeye.se/research/11573…
Redeye tweet media
English
0
0
1
714
Redeye
Redeye@Redeye_·
Redeye Artificial Intelligence (AI) event 2026 last out! 11.35 Smoltek – Magnus Andersson, CEO 11.45 Smart Eye – Jenny Johansson och Stefanie Najafi, VP Industry & Law Enforcement samt VP Sales Industry & Law Enforcement 11.55 Panel discussion with Smoltek and Smart Eye Tune in: redeye.se/events/1139435…
Redeye tweet media
English
0
0
0
587
Redeye
Redeye@Redeye_·
Redeye Artificial Intelligence (AI) event 2026 is progressing! 10.50 Greater Than – Johanna Forseke, Incoming CEO 11.00 Teneo.ai – Per Ottosson, CEO 11.10 Cheffelo – Anton Nytorp, CTO 11.20 Panel discussion with Greater Than, Teneo AI and Cheffelo Tune in: redeye.se/events/1139435…
Redeye tweet media
English
0
0
0
590